SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Stemline Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

NEW YORK, May 1, 2018 /PRNewswire/ — Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Stemline Therapeutics, Inc. (NASDAQ: STML).

If you are a shareholder of Stemline Therapeutics and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at: